Cite
Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives
MLA
Barcellini, Wilma, et al. “Management of Refractory Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation: Current Perspectives.” Journal of Blood Medicine, vol. 10, Aug. 2019, pp. 265–78. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....6ba0145f3d1d3114bf416690071c9582&authtype=sso&custid=ns315887.
APA
Barcellini, W., Fattizzo, B., & Zaninoni, A. (2019). Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives. Journal of Blood Medicine, 10, 265–278.
Chicago
Barcellini, Wilma, Bruno Fattizzo, and Anna Zaninoni. 2019. “Management of Refractory Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation: Current Perspectives.” Journal of Blood Medicine 10 (August): 265–78. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....6ba0145f3d1d3114bf416690071c9582&authtype=sso&custid=ns315887.